PL194344B1 - Zastosowanie pochodnej pirydazynonu - Google Patents

Zastosowanie pochodnej pirydazynonu

Info

Publication number
PL194344B1
PL194344B1 PL99345036A PL34503699A PL194344B1 PL 194344 B1 PL194344 B1 PL 194344B1 PL 99345036 A PL99345036 A PL 99345036A PL 34503699 A PL34503699 A PL 34503699A PL 194344 B1 PL194344 B1 PL 194344B1
Authority
PL
Poland
Prior art keywords
methyl
pyridazinyl
acetamide
tetrahydro
oxo
Prior art date
Application number
PL99345036A
Other languages
English (en)
Polish (pl)
Other versions
PL345036A1 (en
Inventor
Heimo Haikala
Piero Pollesello
Juha Kaivola
Jouko Levijoki
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of PL345036A1 publication Critical patent/PL345036A1/xx
Publication of PL194344B1 publication Critical patent/PL194344B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PL99345036A 1998-06-19 1999-05-26 Zastosowanie pochodnej pirydazynonu PL194344B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/099,945 US5905078A (en) 1998-06-19 1998-06-19 Use of a pyridazinone derivative
PCT/FI1999/000449 WO1999066932A1 (en) 1998-06-19 1999-05-26 New use of a pyridazinone derivative

Publications (2)

Publication Number Publication Date
PL345036A1 PL345036A1 (en) 2001-11-19
PL194344B1 true PL194344B1 (pl) 2007-05-31

Family

ID=22277351

Family Applications (1)

Application Number Title Priority Date Filing Date
PL99345036A PL194344B1 (pl) 1998-06-19 1999-05-26 Zastosowanie pochodnej pirydazynonu

Country Status (18)

Country Link
US (2) US5905078A (cs)
EP (1) EP1087769B1 (cs)
JP (1) JP4938928B2 (cs)
AT (1) ATE261305T1 (cs)
AU (1) AU760379B2 (cs)
BR (1) BR9911237A (cs)
CA (1) CA2334910C (cs)
CZ (1) CZ295283B6 (cs)
DE (1) DE69915475T2 (cs)
EE (1) EE04658B1 (cs)
ES (1) ES2217767T3 (cs)
HU (1) HUP0202836A3 (cs)
IL (2) IL140032A0 (cs)
NZ (1) NZ508444A (cs)
PL (1) PL194344B1 (cs)
SK (1) SK285004B6 (cs)
TR (1) TR200003772T2 (cs)
WO (1) WO1999066932A1 (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20011465A0 (fi) * 2001-07-04 2001-07-04 Orion Corp Pyridatsinonijohdannaisen uusi käyttö
FI20040674A0 (fi) 2004-05-12 2004-05-12 Orion Corp Menetelmä tromboembolisten sairauksien estoon
EP1833480A2 (en) * 2004-11-30 2007-09-19 Artesian Therapeutics, Inc. Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase
AR068814A1 (es) 2007-08-29 2009-12-09 Orion Corp Composicion farmaceutica que comprende levosimendan y un inhibidor de la enzima conversina de la angiotensina (ace), y uso
WO2011027021A1 (en) 2009-09-01 2011-03-10 Orion Corporation A method for the treatment of hypertension
US9915301B2 (en) 2010-10-28 2018-03-13 Ford Global Technologies, Llc Magnetically actuated mechanical diode
US8418825B2 (en) 2010-10-28 2013-04-16 Ford Global Technologies, Llc Magnetically actuated mechanical diode
US9366298B2 (en) 2010-10-28 2016-06-14 Ford Global Technologies, Llc Magnetically actuated clutch assembly
WO2021001601A1 (en) 2019-07-01 2021-01-07 Orion Corporation Methods for administering (r)-n-[4-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)phenyl]acetamide

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3746712A (en) * 1971-06-08 1973-07-17 A Ross 6-(substituted-phenyl)-5-methyl-4,5-dihydro-3(2h)-pyridazinones
US4397854A (en) * 1981-05-14 1983-08-09 Warner-Lambert Company Substituted 6-phenyl-3(2H)-pyridazinones useful as cardiotonic agents
JPS588015A (ja) * 1981-07-06 1983-01-18 Mitsubishi Chem Ind Ltd 強心剤
JP2921933B2 (ja) * 1989-07-14 1999-07-19 帝国臓器製薬株式会社 光学活性酪酸誘導体
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
JP3131845B2 (ja) * 1991-06-12 2001-02-05 帝国臓器製薬株式会社 慢性心不全治療剤
GB9606474D0 (en) * 1996-03-27 1996-06-05 Orion Yhytmo Oy Method for obtaining pure enantiomers of a pyridazinone derivative
JP3163050B2 (ja) 1997-12-25 2001-05-08 三洋電機株式会社 自動洗髪機

Also Published As

Publication number Publication date
WO1999066932A1 (en) 1999-12-29
CZ295283B6 (cs) 2005-06-15
TR200003772T2 (tr) 2001-06-21
IL140032A0 (en) 2002-02-10
EE04658B1 (et) 2006-08-15
ATE261305T1 (de) 2004-03-15
DE69915475T2 (de) 2005-03-24
EP1087769A1 (en) 2001-04-04
AU760379B2 (en) 2003-05-15
NZ508444A (en) 2003-03-28
CZ20004554A3 (en) 2001-05-16
PL345036A1 (en) 2001-11-19
AU4516699A (en) 2000-01-10
SK285004B6 (sk) 2006-04-06
BR9911237A (pt) 2001-03-06
HUP0202836A2 (hu) 2003-02-28
CA2334910A1 (en) 1999-12-29
CA2334910C (en) 2007-10-23
HUP0202836A3 (en) 2003-03-28
US5905078A (en) 1999-05-18
JP2002518450A (ja) 2002-06-25
ES2217767T3 (es) 2004-11-01
EP1087769B1 (en) 2004-03-10
DE69915475D1 (de) 2004-04-15
IL140032A (en) 2007-05-15
JP4938928B2 (ja) 2012-05-23
USRE38102E1 (en) 2003-04-29
EE200000755A (et) 2002-04-15
SK18732000A3 (sk) 2001-12-03

Similar Documents

Publication Publication Date Title
US6248745B1 (en) Pharmaceutical combination comprising a COX-2 inhibitor and a iNOS inhibitor
US4826860A (en) Substituted 2-aminobenzothiazoles and derivatives useful as cerebrovascular agents
RU2328283C2 (ru) Лечение диабета типа 2 ингибиторами дипептидилпептидазы iv
EP1163224B1 (en) N-[2-hydroxy-3-(1-piperidinyl)propoxy]pyridine-1-oxide-3-carboximidoyl chloride and its use in the treatment of insulin resistance
KR830001243B1 (ko) N-(페녹시알킬) 이미다졸 유도체의 제조방법
US5721277A (en) Compounds and methods for inhibiting hyper-proliferative cell growth
EP2834269A1 (en) Methods for improving diaphragm function
PL194344B1 (pl) Zastosowanie pochodnej pirydazynonu
EP1004316B1 (en) Therapeutics for diabetic complications
BG65179B1 (bg) Оптичноактивно производно на пиридил-4н-1,2,4-оксадиазин и приложението му за производство на медикаменти за лечение на съдови заболявания
JPS62289525A (ja) カルシウム調節活性を有する化合物及び製薬組成物
JP2000510824A (ja) エンドセリン拮抗薬を含有することを特徴とする心不全治療剤
Kanda et al. Cardiovascular profile of MPC-1304, a novel dihydropyridine calcium antagonist: comparison with other calcium antagonists
DE69826287T2 (de) Verwendung von phospholambanhemmer zur steigerung der koronäre durchblutung
RU2338538C1 (ru) Антигипотензивное средство
JP2018535192A (ja) １，４−ジ−（４−メチルチオフェニル）−３−フタロイルアゼチジン−２−オンおよびその誘導体
US20110288176A1 (en) Ethacrynic acid-containing composition for prevention or treatment of transglutaminase-related diseases and method for prevention or treatment of transglutaminase-related diseases using the same
JPS5815914A (ja) 強心剤

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20130526